Open Nav
Buzz of BIO

Winners of the 2016 Buzz of BIO Contest announced at the BIO Investor Forum!

Sequella, Inc. is the winner of the "Early Stage Entrepreneurs" category and Quanterix is the winner of the "Late Stage Leaders" category! These two companies will receive a complimentary company presentation, conference registration, and promotion to industry leaders, including a spotlight in BioCentury Extra!

Early Stage Entrepreneur

Late Stage Leader

Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing improved treatments for serious infectious diseases. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats.

Through focused execution, clear commercialization pathways, and strategic partnerships with local and global pharmaceutical companies, Sequella is working to commercialize a broad product portfolio designed to treat infectious disease threats with significant market opportunity.

Sequella's growth strategy leverages a strong management team and core competencies in chemistry, microbiology, molecular biology, infectious diseases, and product development.

Founded in 2007, Quanterix has developed an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today.

The Single Molecule Array (Simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant commercial unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more.

Quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at Tufts University by Dr. David Walt, scientific founder of Quanterix and Illumina (NASDAQ: ILMN).


Ten biotechs were nominated in each of the two categories, "Early Stage Entrepreneurs" and "Late Stage Leaders". 

  • To qualify for the Early Stage Entrepreneur Grand Prize, companies must have raised less than $25 million USD as of July 1, 2016; have been founded after 2011; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category, but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
  • To qualify for the Late Stage Leader Grand Prize, companies must have raised more than $25 million USD as of July 1, 2016 and/or have been founded before 2011.

Please note that the contest was open to U.S. companies only. Read the official contest rules here.